SCHEMBL30872128

SCHEMBL30872128

CCOC(=O)C(C)(c1ccnc(Cl)c1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GPR119 Q8TDV5 7/20 0.41
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
HTR2A P28223 1/20 0.40
PMP22 Q01453 1/20 0.40
PPARA Q07869 1/20 0.40
CNR2 P34972 3/20 0.39
IDE P14735 1/20 0.37
AAK1 Q2M2I8 2/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SMARCA2 P51531 1/20 0.36
SMARCA4 P51532 1/20 0.36
NOS1 P29475 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30872131 1.00 ALDH1A1 (0.41) ALDH1A1GAAL3MBTL1GPR119ABCB11
SCHEMBL1979700 0.85 CNR2 (0.50) ALDH1A1GAAL3MBTL1GPR119ABCB11
SCHEMBL24355439 0.81 GAA (0.49) ALDH1A1GAAL3MBTL1ABCB11CYP1A2
SCHEMBL30872138 0.80 SMARCA2 (0.38) CYP1A2AAK1SMARCA2SMARCA4
SCHEMBL2183357 0.79 GAA (0.40) ALDH1A1GAAL3MBTL1GPR119ABCB11
SCHEMBL28008253 0.75 PIN1 (0.49) ALDH1A1CYP1A2TSHRSMN1; SMN2
SCHEMBL30184947 0.74 SMARCA2 (0.37) ALDH1A1GAAL3MBTL1AAK1SMARCA2
SCHEMBL13332664 0.71 GPR119 (0.44) ALDH1A1GAAL3MBTL1GPR119CYP3A4
SCHEMBL1979197 0.71 GPR119 (0.44) ALDH1A1GAAL3MBTL1GPR119CYP3A4
SCHEMBL22548067 0.71 RECQL (0.37) AAK1SMARCA2SMARCA4NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940404-A Tricyclic compounds as Cbl-b inhibitors 海南先声再明医药股份有限公司 2024-04-26 CN disclosed